ReviewBioresources and bioprocessing2026
Green bioconversion of insoluble chitin: chitinase development pathways via multi-strategy synergy.
Review in Bioresources and bioprocessing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Extreme Biomimetics: Achievements and Fundamental Challenges for the Future.Biomimetics (Basel, Switzerland) · 2026Review
- Reengineering a thermostable keratinase past the boiling point.Applied and environmental microbiology · 2026Article
- Recent Advances and Applications of Chitin and Chitosan Hydrogel Scaffolds in Tissue Engineering.Gels (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
As one of the most abundant natural polysaccharides on Earth, chitin is limited in its high-value utilization by its natural insolubility and high crystalline structure. Enzymatic degradation-especially via chitinases-serves as a highly promising approach for the green bioconversion of insoluble chitin. This review systematically analyzes the structural barriers that hinder the degradation of insoluble chitin and elucidates the enzymatic hydrolysis mechanisms underlying its conversion. Recent advances in enhancing chitinase catalytic efficiency through protein engineering approaches-including directed evolution, rational design, and domain fusion-are comprehensively discussed. In addition, the review highlights the multi-strategy synergistic frameworks that integrate AI-assisted enzyme design, immobilization technology, and expression regulation to achieve high-performance chitin bioconversion, which is intended to provide valuable references for the efficient bioconversion and resource recycling of insoluble chitin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.